Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Leukemia 1Hematologic Neoplasms 1Anxiety Disorders 1

Interventions

Psychiatric Rehabilitation 2Ketamine 2Behavior Therapy 2Uncertainty 1Touch 1Therapeutics 1Therapeutic Touch 1Standard of Care 1Single Person 1Psychosocial Intervention 1Practice Guidelines as Topic 1Pharmacogenomic Testing 1Midazolam 1Interviews as Topic 1Imagery, Psychotherapy 1Hypnosis 1Glutamyl Aminopeptidase 1Control Groups 1Cognitive Behavioral Therapy 1Analgesia 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Midazolam × Other hematologic neoplasm × Clear all
NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated
10 enrolled
LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡